SOBRsafe Secures $2.0 Million in Private Placement Funding Through H.C. Wainwright

SOBRsafe Inc., trading on NASDAQ under the ticker SOBR, has entered into definitive agreements for a private placement offering expected to generate approximately $2.0 million in gross proceeds. The transaction involves the issuance and sale of 1,290,324 shares of common stock, or pre-funded warrants in lieu thereof, along with Series C and Series D warrants. Each series of warrants provides the right to purchase up to an aggregate of 1,290,324 additional shares. The combined purchase price for each share, or pre-funded warrant, and its associated warrants is $1.55.

The financing was structured as an at-the-market offering under Nasdaq rules, with H.C. Wainwright & Co. acting as the exclusive placement agent. The warrants issued in this placement carry an exercise price of $1.30 per share and are exercisable immediately. The Series C warrants have a term of five years from the effective date of the applicable resale registration statement, while the Series D warrants expire twenty-four months after that date. Net proceeds from the offering are intended for working capital and general corporate purposes, which will support the company's ongoing operations and strategic initiatives.

This capital infusion is significant for SOBRsafe, a company that positions itself as a leader in next-generation alcohol monitoring and detection technology. The company's core innovation is its advanced transdermal technology, which detects the presence of alcohol as it is emitted through a user's skin. This touch-based method represents a shift from traditional testing that requires breath, blood, or urine samples. The technology enables real-time detection and reporting, offering a passive and dignified screening solution.

The implications of this funding extend to the markets SOBRsafe serves, which include behavioral health, family law, and consumer sectors. The company also offers its technology for licensing and integration. By securing $2.0 million, SOBRsafe gains financial resources to further develop its backend data platform and expand the application of its technology. For industries reliant on reliable sobriety monitoring, such as rehabilitation centers or legal systems managing custody cases, advancements in passive, non-invasive testing could improve compliance monitoring and user experience. The company's news and updates are available in its newsroom at https://ibn.fm/SOBR.

For the investment community, this private placement demonstrates continued institutional interest in specialized health and safety technology firms. H.C. Wainwright's role as placement agent adds a layer of validation for the transaction. The structure of the offering, including immediately exercisable warrants with multi-year terms, is designed to provide both immediate capital and potential future equity financing. The full details of the press release can be viewed at https://ibn.fm/RC1sW. As SOBRsafe deploys these funds, the focus will be on how the technology evolves and penetrates its target markets, potentially setting new standards for alcohol detection and monitoring.